“I worked with Jim at Daiichi Sankyo. He lead a group publishing FDA submissions. He is detail oriented and a very good "people-person". He understands publishing tools and was an excellent resource for technical publishing questions.”
About
Biopharmaceutical Regulatory Operations executive with extensive experience in submission…
Activity
-
Transformational Thursday: **🌍 eCTD Global Implementation Status 2024: A Digital Transformation in Regulatory Submissions** As we move further…
Transformational Thursday: **🌍 eCTD Global Implementation Status 2024: A Digital Transformation in Regulatory Submissions** As we move further…
Liked by Jim Zhang
-
This post is a month overdue but it’s been a very busy month! I recently decided to step away from my work family at EVERSANA INTOUCH to start a new…
This post is a month overdue but it’s been a very busy month! I recently decided to step away from my work family at EVERSANA INTOUCH to start a new…
Liked by Jim Zhang
-
It was a great session. Thanks, Brooke for leading the session development and moderating the panel discussion.
It was a great session. Thanks, Brooke for leading the session development and moderating the panel discussion.
Liked by Jim Zhang
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Volunteer Experience
-
Volunteer
Habitat for Humanity New York City
- Present 7 years 9 months
Disaster and Humanitarian Relief
Recommendations received
2 people have recommended Jim
Join now to viewMore activity by Jim
-
This evening, our Scholar Rock colleagues will present a family-friendly poster at the #2024SMAConference highlighting the role of muscle in SMA and…
This evening, our Scholar Rock colleagues will present a family-friendly poster at the #2024SMAConference highlighting the role of muscle in SMA and…
Liked by Jim Zhang
-
On May 29, 2024, FDA notified selected participants of their acceptance into the Support for clinical Trials Advancing Rare disease Therapeutics…
On May 29, 2024, FDA notified selected participants of their acceptance into the Support for clinical Trials Advancing Rare disease Therapeutics…
Liked by Jim Zhang
-
FDA plans to release a draft guidance this year on the use of artificial intelligence/machine learning to support drug development. The guidance will…
FDA plans to release a draft guidance this year on the use of artificial intelligence/machine learning to support drug development. The guidance will…
Liked by Jim Zhang
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Jim Zhang in United States
-
Jim Zhang
-
Jim Zhang
Senior Associate at KPMG
-
Jim Zhang
-
Jim Zhang
Economics & Statistics @ University of Pennsylvania
-
Jim Zhang
Structural Biology PhD Student at Stanford University
481 others named Jim Zhang in United States are on LinkedIn
See others named Jim Zhang